Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pradeep Natarajan

Showing results (1-10 of 508) with videos related to

Pageof 51
Sort By:
Journal of the American College of Cardiology|October 13, 2018
Polygenic Risk Scoring for Coronary Heart Disease: The First Risk FactorPradeep Natarajan
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2022
Genomic Aging, Clonal Hematopoiesis, and Cardiovascular DiseasePradeep Natarajan
The New England Journal of Medicine|May 29, 2024
Exceptional Genetics, Generalizable Therapeutics, and Coronary Artery DiseasePradeep Natarajan
JAMA Cardiology|June 9, 2021
Clinical Utility of Lipoprotein(a) for Screening Does Not Determine Clinical Utility of Lipoprotein(a) for the Patient-ReplyMark Trinder, Pradeep Natarajan
JAMA Cardiology|December 22, 2021
Lifestyle Modification Is Appropriate as Primary Prevention-ReplyRomit Bhattacharya, Pradeep Natarajan
The New England Journal of Medicine|October 18, 2023
Familial Clonal Hematopoiesis in a Long Telomere SyndromeTetsushi Nakao, Pradeep Natarajan
Nature Cardiovascular Research|November 7, 2022
Clonal hematopoiesis, multi-omics and coronary artery diseaseTetsushi Nakao, Pradeep Natarajan
Nature Reviews. Cardiology|November 23, 2021
Clinical utility of polygenic risk scores for coronary artery diseaseDerek Klarin, Pradeep Natarajan
Cell|May 21, 2016
PCSK9 InhibitorsPradeep Natarajan, Sekar Kathiresan
Journal of the American College of Cardiology|February 14, 2024
Differences in Circulating Progenitor Cells and Risk of Atherosclerotic Cardiovascular Disease in South Asian IndividualsPradeep Natarajan, Aniruddh P Patel
Pageof 51

Showing results (1-10 of 508) with videos related to

Sort By:
Pageof 51
Journal of the American College of Cardiology|October 13, 2018
Polygenic Risk Scoring for Coronary Heart Disease: The First Risk FactorPradeep Natarajan
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2022
Genomic Aging, Clonal Hematopoiesis, and Cardiovascular DiseasePradeep Natarajan
The New England Journal of Medicine|May 29, 2024
Exceptional Genetics, Generalizable Therapeutics, and Coronary Artery DiseasePradeep Natarajan
JAMA Cardiology|June 9, 2021
Clinical Utility of Lipoprotein(a) for Screening Does Not Determine Clinical Utility of Lipoprotein(a) for the Patient-ReplyMark Trinder, Pradeep Natarajan
JAMA Cardiology|December 22, 2021
Lifestyle Modification Is Appropriate as Primary Prevention-ReplyRomit Bhattacharya, Pradeep Natarajan
The New England Journal of Medicine|October 18, 2023
Familial Clonal Hematopoiesis in a Long Telomere SyndromeTetsushi Nakao, Pradeep Natarajan
Nature Cardiovascular Research|November 7, 2022
Clonal hematopoiesis, multi-omics and coronary artery diseaseTetsushi Nakao, Pradeep Natarajan
Nature Reviews. Cardiology|November 23, 2021
Clinical utility of polygenic risk scores for coronary artery diseaseDerek Klarin, Pradeep Natarajan
Cell|May 21, 2016
PCSK9 InhibitorsPradeep Natarajan, Sekar Kathiresan
Journal of the American College of Cardiology|February 14, 2024
Differences in Circulating Progenitor Cells and Risk of Atherosclerotic Cardiovascular Disease in South Asian IndividualsPradeep Natarajan, Aniruddh P Patel
Pageof 51